Background: The Institute of Medicine (IOM) and Department of Health and Human Services (DHHS) have released core indicators of retention in HIV care calculated based upon attended clinic visits (2 visits at defined intervals per 12 month period). Recent research suggests missed clinic visits may capture distinct aspects of retention from measures based upon attended visits. We evaluated associations between the IOM and DHHS retention measures and all-cause mortality, and further assessed the added prognostic value of missed visits when used in conjunction with these core indicators. Methodology: HIV-infected patients initiating ART at 5 CNICS sites from 2000-11 were included. Retention in care over 24-months (mos) following ART start was measured using the IOM (HRSA HAB measure) and DHHS core indicators, and as a count of missed (no show) clinic visits. Separate Cox models evaluated the relationship between retention measures and all-cause mortality with follow-up time starting at 24 mos. Next, separate Cox models evaluated the association between missed visits and all-cause mortality among the subset of patients classified as retained according to the IOM and DHHS core indicators. Models controlled for age, race, gender, site, baseline CD4 and VL. Results: Among 3926 patients (mean age 38, 81% male, 54% white, 47% CD4<200, 42% VL>100K), 64% and 59% met the IOM and DHHS retention core indicators, respectively, and 32% had zero missed visits over 24-mos following ART start. Subsequently, 333 patients (8.5%) died during 17841 person-years follow-up. In separate multivariable Cox models, failure to achieve the IOM indicator (HR=2.2; 95%CI=1.8-2.8), the DHHS indicator (2.4; 1.9-3.0), and missed clinic visits at 24-mos (1-2 no shows: 2.0; 1.5-2.8, >2 no shows: 3.2; 2.4-4.5) were all associated with increased long-term mortality. Roughly two-thirds of patients classified as retained by the IOM and DHHS core indicators had one or more no show clinic visits in the 24-mos following ART start. Separate multivariable Cox models restricted to patients classified as retained by the IOM and DHHS core indicators demonstrated increased mortality risk among patients with more missed clinic visits (IOM: 1-2 no shows 1.8; 1.2-2.7, >2 no shows: 3.7; 2.4-5.6 and DHHS: 1-2 no shows 1.7; 1.1-2.6, >2 no shows: 3.7; 2.3-5.8). Conclusions: These data are among the first to provide empirical validation of the IOM and DHHS core indicators of retention in care with clinical outcomes. Both measures were strongly associated with long-term mortality among ART initiators. However, study findings suggest assessment of missed clinic visits, in conjunction with these core indicators, can meaningfully enhance prognostic value for all-cause mortality, with implications for health care policy and clinical care.